Drug intelligence / Profile preview

ringers lactate + hydroxyethyl starch + norepinephrine + dobutamine

Development stage
Unknown
Modality
Small Molecules
Administration
Intravenous
01

Overview

This is a combination therapy consisting of two intravenous fluids (Ringer's lactate and hydroxyethyl starch) and two cardiovascular medications (norepinephrine and dobutamine). This combination may be used in the management of septic shock and other forms of shock. **Components:** 1. **Ringer's lactate**: An isotonic crystalloid solution used for fluid resuscitation that contains sodium lactate, which can help correct metabolic acidosis. 2. **Hydroxyethyl starch**: A synthetic colloid volume expander used to maintain oncotic pressure and expand plasma volume. Available as products like Voluven (6% hydroxyethyl starch 130/0.4) or Hextend (6% hetastarch in lactated electrolyte injection). 3. **Norepinephrine**: A vasopressor that increases blood pressure through vasoconstriction, primarily used in hypotensive states. 4. **Dobutamine**: An inotropic agent that increases cardiac output by enhancing myocardial contractility without significant vasoconstriction. In septic shock management, Ringer's lactate and hydroxyethyl starch may be used for initial fluid resuscitation, followed by norepinephrine to maintain blood pressure, with dobutamine added to improve cardiac output in patients with myocardial dysfunction.

02

Targets

ADRA1A (α1A)ADRB1 (β1)

Beyond the preview

Go deeper on ringers lactate + hydroxyethyl starch + norepinephrine + dobutamine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ringers lactate + hydroxyethyl starch + norepinephrine + dobutamine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call